Browsing by author "AHern, Roger"
Now showing items 1-6 of 6
-
Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer.
(2012-05)BACKGROUND:The immunohistochemical (IHC) 4+C score is a cost-effective prognostic tool that uses clinicopathologic factors and four standard IHC assays: oestrogen receptor (ER), PR, HER2 and Ki67. We assessed its utility ... -
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.
(2014-04)Micropapillary carcinoma (MPC) is a rare histological special type of breast cancer, characterized by an aggressive clinical behaviour and a pattern of copy number aberrations (CNAs) distinct from that of grade- and oestrogen ... -
Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer.
(2006-02)The study of changes in proliferation as a marker of treatment benefit during presurgical endocrine treatment of breast cancer has become increasingly popular, particularly using the nuclear marker Ki67, and holds the ... -
Short-term presurgical treatment for all?
(BIOMED CENTRAL LTD, 2007-02) -
Test of association between variant tgβ1 alleles and late adverse effects of breast radiotherapy.
(2010-10)To test for association between single nucleotide polymorphisms at the TGFβ1 locus and the risk of late normal tissue injury following whole breast radiotherapy.A retrospective study compared the number of variant alleles ...
